Uncategorized
Anti-VEGFs improve visual acuity in early stages of treatment for wet AMD
ORLANDO, Fla. — Visual acuity improved in early stages of treatment with anti-VEGF injections for neovascular age-related macular degeneration, according to a study presented here at the Association for Research in Vision and Ophthalmology meeting. “The most dramatic improvement in visual acuity is seen during the early treatment months, followed by a plateau,” Miin Roh, MD, and colleagues said in a poster presentation.